These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 7530159

  • 1. Competitive binding experiments reveal differential interactions for dihydropyridine calcium channel activators and antagonists at dihydropyridine receptors on mouse brain membranes.
    O'Neill SK, Triggle CR, Bolger GT.
    Can J Physiol Pharmacol; 1994 Jul; 72(7):738-45. PubMed ID: 7530159
    [Abstract] [Full Text] [Related]

  • 2. Analysis of the properties of binding of calcium-channel activators and inhibitors to dihydropyridine receptors in chick heart membranes.
    Maan AC, Hosey MM.
    Circ Res; 1987 Sep; 61(3):379-88. PubMed ID: 2441891
    [Abstract] [Full Text] [Related]

  • 3. Comparative behavioral, neurochemical and pharmacological activities of dihydropyridine calcium channel activating drugs.
    O'Neill SK, McKay DW, Campbell N, Triggle CR, Crowley M, Bolger GT.
    J Pharmacol Exp Ther; 1990 Jun; 253(3):905-12. PubMed ID: 1694243
    [Abstract] [Full Text] [Related]

  • 4. Pharmacologic and radioligand binding analysis of the actions of 1,4-dihydropyridine activator-antagonist pairs in smooth muscle.
    Wei XY, Luchowski EM, Rutledge A, Su CM, Triggle DJ.
    J Pharmacol Exp Ther; 1986 Oct; 239(1):144-53. PubMed ID: 2428971
    [Abstract] [Full Text] [Related]

  • 5. The effects of strychnine on the regulation of voltage-dependent calcium channels by dihydropyridines in brain and heart.
    O'Neill SK, Bolger GT.
    Pharmacol Biochem Behav; 1990 Apr; 35(4):833-40. PubMed ID: 1693213
    [Abstract] [Full Text] [Related]

  • 6. Dihydropyridine-sensitive Ca2+ channels: molecular properties of interaction with Ca2+ channel blockers, purification, subunit structure, and differentiation.
    Lazdunski M, Barhanin J, Borsotto M, Fosset M, Galizzi JP, Renaud JF, Romey G, Schmid A.
    J Cardiovasc Pharmacol; 1986 Apr; 8 Suppl 8():S13-9. PubMed ID: 2433514
    [Abstract] [Full Text] [Related]

  • 7. Competitive and cooperative effects of Bay K8644 on the L-type calcium channel current inhibition by calcium channel antagonists.
    Zahradníková A, Minarovic I, Zahradník I.
    J Pharmacol Exp Ther; 2007 Aug; 322(2):638-45. PubMed ID: 17475903
    [Abstract] [Full Text] [Related]

  • 8. Specific binding of a calcium channel activator, [3H]BAY k 8644, to membranes from cardiac muscle and brain.
    Janis RA, Rampe D, Sarmiento JG, Triggle DJ.
    Biochem Biophys Res Commun; 1984 May 31; 121(1):317-23. PubMed ID: 6203531
    [Abstract] [Full Text] [Related]

  • 9. Kinetics of binding of dihydropyridine calcium channel ligands to skeletal muscle membranes: evidence for low-affinity sites and for the involvement of G proteins.
    Dunn SM, Bladen C.
    Biochemistry; 1991 Jun 11; 30(23):5716-21. PubMed ID: 1645998
    [Abstract] [Full Text] [Related]

  • 10. Influence of Mg++ on the effect of diltiazem to increase dihydropyridine binding to receptors on Ca++-channels in chick cardiac and skeletal muscle membranes.
    Maan AC, Ptasienski J, Hosey MM.
    J Pharmacol Exp Ther; 1986 Dec 11; 239(3):768-74. PubMed ID: 2432217
    [Abstract] [Full Text] [Related]

  • 11. Effects of N- and L-type calcium channel antagonists and (+/-)-Bay K8644 on nerve-induced catecholamine secretion from bovine perfused adrenal glands.
    O'Farrell M, Ziogas J, Marley PD.
    Br J Pharmacol; 1997 Jun 11; 121(3):381-8. PubMed ID: 9179377
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Enantiomer selectivity and the development of tolerance to the behavioral effects of the calcium channel activator BAY K 8644.
    O'Neill SK, Bolger GT.
    Brain Res Bull; 1988 Dec 11; 21(6):865-72. PubMed ID: 2465070
    [Abstract] [Full Text] [Related]

  • 14. Calcium channel 'agonist' BAY K 8644 inhibits calcium antagonist binding to brain and PC12 cell membranes.
    Greenberg DA, Cooper EC, Carpenter CL.
    Brain Res; 1984 Jul 09; 305(2):365-8. PubMed ID: 6204725
    [Abstract] [Full Text] [Related]

  • 15. Two calcium channels in basolateral membranes of rabbit ileal epithelial cells.
    Homaidan FR, Donowitz M, Weiland GA, Sharp GW.
    Am J Physiol; 1989 Jul 09; 257(1 Pt 1):G86-93. PubMed ID: 2473655
    [Abstract] [Full Text] [Related]

  • 16. Selective antagonism of calcium channel activators by fluspirilene.
    Kenny BA, Fraser S, Kilpatrick AT, Spedding M.
    Br J Pharmacol; 1990 Jun 09; 100(2):211-6. PubMed ID: 1696149
    [Abstract] [Full Text] [Related]

  • 17. [3H]diltiazem binding to calcium channel antagonists recognition sites in rat cerebral cortex.
    Schoemaker H, Langer SZ.
    Eur J Pharmacol; 1985 May 08; 111(2):273-7. PubMed ID: 2410283
    [Abstract] [Full Text] [Related]

  • 18. Interaction of the calcium channel activating 3H-BAY K 8644 and inhibiting 3H-verapamil with specific receptor sites on cultured beating myocardial cells.
    Bellemann P.
    J Recept Res; 1984 May 08; 4(1-6):571-85. PubMed ID: 6084713
    [Abstract] [Full Text] [Related]

  • 19. Separate [3H]-nitrendipine binding sites in mitochondria and plasma membranes of bovine adrenal medulla.
    Ballesta JJ, Garcia AG, Gutierrez LM, Hidalgo MJ, Palmero M, Reig JA, Viniegra S.
    Br J Pharmacol; 1990 Sep 08; 101(1):21-6. PubMed ID: 1704272
    [Abstract] [Full Text] [Related]

  • 20. Characteristics of the binding of [3H]nitrendipine to rabbit ventricular membranes: modification by other Ca++ channel antagonists and by the Ca++ channel agonist Bay K 8644.
    Janis RA, Sarmiento JG, Maurer SC, Bolger GT, Triggle DJ.
    J Pharmacol Exp Ther; 1984 Oct 08; 231(1):8-15. PubMed ID: 6208356
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.